Mochida Pharmaceutical Co., Ltd.
News Releases
Contact us
JA
EN
Search
About Mochida
Sustainability
Investor Relations
Menu
About Mochida
Message from the President
Motto / Corporate Philosophy
Corporate Overview
Officers
History
Location
Management Strategy
Value Creation Process
Materiality
Long-term Vision
Medium-term Management Plan
Business Activities
Pharmaceutical Business
Biomaterials Business
Healthcare Business
Development Pipeline
About Our Group
List of Various Guidelines and Regulations
Sustainability
Basic Sustainability Policy
and Promotion Structure
Materiality
Environment
Society
Corporate Governance
ESG Data
Integrated Report
Investor Relations
Message from the President
Financial Highlights
Corporate Governance
IR Calendar
IR News
IR Library
Financial Results
Presentation Materials
Integrated Report
Shareholder / Stock Information
Stock Information
Shareholder Meeting
IR Disclaimer
Search
HOME
About Mochida
Message from the President
Motto / Corporate Philosophy
Corporate Overview
Management Strategy
Value Creation Process
Materiality
Long-term Vision
Medium-term Management Plan
Location
Business Activities
Pharmaceutical Business
Biomaterials Business
Healthcare Business
Officers
History
About Our Group
List of Various Guidelines and Regulations
Sustainability
Basic Sustainability Policy and Promotion Structure
Materiality
Environment
Basic Environmental Policy and Promotion of Environmental Activities
Information Disclosure Based on the TCFD Recommendation
Environmental Initiatives
Society
Respect for Human Rights
Sustainable procurement
Development and Use of Human Resources
Relations with Society and Local Communities
Governance
ESG Data
Investor Relations
IR News
Message from the President
Corporate Governance
IR Calendar
Financial Highlights
Shareholder / Stock Information
Stock Information
Shareholder Meeting
IR Library
Financial Results
Presentation Materials
Integrated Report
IR Disclaimer
News Releases
Serch
JA
EN
Site Map
Handling of Personal Information
Terms of Use
Contact us
Copyright © MOCHIDA PHARMACEUTICAL CO., LTD.
All Rights Reserved
Search
Business Activities
Healthcare Business
Research & Development
Shareholder
Pharmaceutical Business
Close
HOME
Investor Relations
IR Library
Financial Results
Financial Results
FY2024
FY2023
FY2022
February 7, 2025
[Summary] Consolidated Financial Results for the Nine Months Ended December 31, 2024 (PDF 618KB)
November 1, 2024
[Summary] Consolidated Financial Results for the Six Months Ended September 30, 2024 (PDF 774KB)
August 2, 2024
[Summary] Consolidated Financial Results for the Three Months Ended June 30, 2024 (PDF 721KB)
May 13, 2024
[Summary] Consolidated Financial Results for the Year Ended March 31, 2024 (PDF 736KB)
February 5, 2024
[Summary] Consolidated Financial Results for the Nine Months Ended December 31, 2023 (PDF 894KB)
November 2, 2023
[Summary] Consolidated Financial Results for the Six Months Ended September 30, 2023 (PDF 778KB)
August 4, 2023
[Summary] Consolidated Financial Results for the Three Months Ended June 30, 2023 (PDF 677KB)
May 15, 2023
[Summary]Consolidated Financial Results for the Year Ended March 31, 2023 (PDF 561KB)
Page top